Cutler Group’s Ginkgo Bioworks DNA Stock Holding History

Cutler Group’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$8K	Sell	193 -5	-3%	-$259	﹤0.01%	1366
2023 Q4	$13K	Sell	198 -95	-32%	-$5.82K	﹤0.01%	2223
2023 Q3	$21K	Buy	293 +14	+5%	+$1.12K	﹤0.01%	1986
2023 Q2	$20K	Sell	279 -94	-25%	-$5.56K	﹤0.01%	1843
2023 Q1	$19K	Buy	373 +34	+10%	+$2.15K	﹤0.01%	1946
2022 Q4	$22K	Buy	339 +146	+76%	+$13.4K	﹤0.01%	2140
2022 Q3	$24K	Sell	193 -397	-67%	-$47.3K	﹤0.01%	2465
2022 Q2	$56K	Buy	590 +61	+12%	+$7.44K	﹤0.01%	1863
2022 Q1	$85K	Sell	529 -123	-19%	-$23.9K	﹤0.01%	1814
2021 Q4	$216K	Buy	652 +148	+29%	+$70.3K	0.01%	1255
2021 Q3	$233K	Buy	+504	New	+$245K	0.01%	1252

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cutler Group's DNA Position: Q1 2024 in Review

Cutler Group reduced its Ginkgo Bioworks (DNA) stake by 2.5% in Q1 2024, selling an estimated $259 and leaving 193 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Cutler Group first reported a position in DNA in Q3 2021 and has held it in 11 quarters since. The position peaked at $233K in Q3 2021. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

Cutler Group held 193 shares of Ginkgo Bioworks worth $8K as of Q1 2024.
Cutler Group sold 5 Ginkgo Bioworks shares in Q1 2024, an estimated $259.
Ginkgo Bioworks made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1366 holding.
Cutler Group first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 11 quarters since.
Cutler Group's Ginkgo Bioworks position peaked at $233K in Q3 2021.
342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.